BIOMAT Database Logo BIOMAT Database Logo

Brief executive-function assessment tool: A new cognitive impairment screening tool for alcohol and other drug services. 2022

J Berry, and E A Shores, and T Nardo, and A Sedwell, and J Lunn, and E M Marceau, and A Wesseling, and M Zucco, and S Sugden-Lingard, and T Borchard, and J Batchelor
Advanced Neuropsychological Treatment Services, Sydney, Australia.

Accurate screening for cognitive impairment in alcohol and other drug (AOD) services would help to identify individuals who may need supports to obtain the greatest benefit from substance use disorder (SUD) treatment. At present there is no screening measure that has been developed specifically to detect cognitive impairment in a SUD population. This study examines the psychometric properties of the Brief Executive-function Assessment Tool (BEAT), which was specifically designed for this purpose. This study involving 501 individuals with SUD and 145 normal control participants established internal consistency (n = 646; 0.734), interrater (n = 60; 0.994), and test-retest reliability (n = 177; 0.845), and construct (all correlations p ≤ 0.05), and criterion (n = 467; ANCOVA p < 0.001) validity. Test operating characteristics (n = 500; 87% sensitivity, 71% specificity, 21% PPP, and 99% NPP) were also established relative to an independent criterion variable made up of three established performance-based neuropsychological tests. Findings support the reliability and validity of the BEAT as a screening measure of executive function impairment with high sensitivity and a low rate of false negatives.

UI MeSH Term Description Entries
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D011594 Psychometrics Assessment of psychological variables by the application of mathematical procedures. Psychometric
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D056344 Executive Function A set of cognitive functions that controls complex, goal-directed thought and behavior. Executive function involves multiple domains, such as CONCEPT FORMATION, goal management, cognitive flexibility, INHIBITION control, and WORKING MEMORY. Impaired executive function is seen in a range of disorders, e.g., SCHIZOPHRENIA; and ADHD. Executive Control,Executive Controls,Executive Functions,Function, Executive,Functions, Executive
D060825 Cognitive Dysfunction Diminished or impaired mental and/or intellectual function. Cognitive Disorder,Mild Cognitive Impairment,Cognitive Decline,Cognitive Impairments,Mental Deterioration,Cognitive Declines,Cognitive Disorders,Cognitive Dysfunctions,Cognitive Impairment,Cognitive Impairment, Mild,Cognitive Impairments, Mild,Decline, Cognitive,Declines, Cognitive,Deterioration, Mental,Deteriorations, Mental,Disorder, Cognitive,Disorders, Cognitive,Dysfunction, Cognitive,Dysfunctions, Cognitive,Impairment, Cognitive,Impairment, Mild Cognitive,Impairments, Cognitive,Impairments, Mild Cognitive,Mental Deteriorations,Mild Cognitive Impairments

Related Publications

J Berry, and E A Shores, and T Nardo, and A Sedwell, and J Lunn, and E M Marceau, and A Wesseling, and M Zucco, and S Sugden-Lingard, and T Borchard, and J Batchelor
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.
April 2005, Journal of the American Geriatrics Society,
J Berry, and E A Shores, and T Nardo, and A Sedwell, and J Lunn, and E M Marceau, and A Wesseling, and M Zucco, and S Sugden-Lingard, and T Borchard, and J Batchelor
Memory and Executive Screening (MES): a brief cognitive test for detecting mild cognitive impairment.
October 2012, BMC neurology,
J Berry, and E A Shores, and T Nardo, and A Sedwell, and J Lunn, and E M Marceau, and A Wesseling, and M Zucco, and S Sugden-Lingard, and T Borchard, and J Batchelor
Validation of a new mass screening tool for cognitive impairment: Cognitive Assessment for Dementia, iPad version.
January 2013, Clinical interventions in aging,
J Berry, and E A Shores, and T Nardo, and A Sedwell, and J Lunn, and E M Marceau, and A Wesseling, and M Zucco, and S Sugden-Lingard, and T Borchard, and J Batchelor
Neurocognitive impairment in addiction: A digital tool for executive function assessment.
January 2022, Frontiers in psychiatry,
J Berry, and E A Shores, and T Nardo, and A Sedwell, and J Lunn, and E M Marceau, and A Wesseling, and M Zucco, and S Sugden-Lingard, and T Borchard, and J Batchelor
The Brief Memory and Executive Test (BMET): A cognitive screening tool to detect and differentiate vascular cognitive impairment and Alzheimer's disease.
February 2018, International journal of geriatric psychiatry,
J Berry, and E A Shores, and T Nardo, and A Sedwell, and J Lunn, and E M Marceau, and A Wesseling, and M Zucco, and S Sugden-Lingard, and T Borchard, and J Batchelor
Brief Memory and Executive Test: evaluation of a new screening test for cognitive impairment due to small vessel disease.
March 2012, Age and ageing,
J Berry, and E A Shores, and T Nardo, and A Sedwell, and J Lunn, and E M Marceau, and A Wesseling, and M Zucco, and S Sugden-Lingard, and T Borchard, and J Batchelor
[The Imon Cognitive Impairment Screening Test (ICIS): A new brief screening test for mild cognitive impairment or dementia].
January 2014, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
J Berry, and E A Shores, and T Nardo, and A Sedwell, and J Lunn, and E M Marceau, and A Wesseling, and M Zucco, and S Sugden-Lingard, and T Borchard, and J Batchelor
The Beijing version of the Montreal Cognitive Assessment as a brief screening tool for mild cognitive impairment: a community-based study.
September 2012, BMC psychiatry,
J Berry, and E A Shores, and T Nardo, and A Sedwell, and J Lunn, and E M Marceau, and A Wesseling, and M Zucco, and S Sugden-Lingard, and T Borchard, and J Batchelor
The Montreal Cognitive Assessment: A Pilot Study of a Brief Screening Tool for Mild and Moderate Cognitive Impairment in HIV-Positive Veterans.
January 2015, Journal of the International Association of Providers of AIDS Care,
J Berry, and E A Shores, and T Nardo, and A Sedwell, and J Lunn, and E M Marceau, and A Wesseling, and M Zucco, and S Sugden-Lingard, and T Borchard, and J Batchelor
Assessment of Mild Cognitive Impairment Using CogEvo: A Computerized Cognitive Function Assessment Tool.
January 2024, Journal of primary care & community health,
Copied contents to your clipboard!